Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Urologic Oncology|February 25, 2026
Cell-surface targets for prostate cancer therapeuticsSamuel Ruder, Pardis Ziaeefar, Ambika P Jaswal, et al.
Frontiers in Medicine|June 27, 2017
[<sup>68</sup>Ga]/[<sup>188</sup>Re] Complexed [CDTMP] Trans-1,2-Cyclohexyldinitrilotetraphosphonic Acid As a Theranostic Agent for Skeletal MetastasesAmbika P Jaswal, Virendra K Meena, Surbhi Prakash, et al.
EJNMMI Radiopharmacy and Chemistry|August 14, 2023
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [<sup>225</sup>Ac]Ac-DOTA-TDA-Lipiodol<sup>®</sup> against hepatic tumorsAnders Josefsson, Angel G Cortez, Harikrishnan Rajkumar, et al.
Expert Review of Clinical Immunology|October 15, 2024
Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBMMichal Nisnboym, Chaim T Sneiderman, Ambika P Jaswal, et al.
ACS Omega|November 29, 2023
Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET AgentsZehua Sun, Ambika P Jaswal, Xiaojie Chu, et al.
Molecular Cancer Therapeutics|July 23, 2025
Targeting Tumor-Infiltrating Immune Cells for Targeted Alpha Therapy in Gliomas: Optimization of [225Ac]Ac-DOTA-αCD11b Dosing through PET ImagingAmbika P Jaswal, Anders Josefsson, Angel G Cortez, et al.
Molecular Cancer Therapeutics|July 10, 2025
Targeting tumor-infiltrating immune cells for targeted alpha therapy in gliomas: Optimization of [225Ac]Ac-DOTA-αCD11b dosing through PET-imagingAmbika P Jaswal, Anders Josefsson, Angel G Cortez, et al.
Molecular Cancer Therapeutics|February 6, 2025
Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid TumorsJeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee, et al.
Scientific Reports|March 4, 2024
ImmunoPET imaging of TIGIT in the glioma microenvironmentSarah R Vincze, Ambika P Jaswal, Stephen C Frederico, et al.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Pageof 2